Diabetic Foot Ulcer Follow-Up Program for Saudi Hospitals: Keeping High-Risk Feet Under Review
A diabetic foot ulcer follow-up program is a hospital pathway that records each patient's foot risk, schedules foot checks and wound reviews, tracks referrals to podiatry, vascular and surgical teams, and recalls patients who miss visits. Saudi studies of diabetic foot admissions report high amputation rates, which makes reliable follow-up an operational priority rather than an afterthought.
Key takeaways
- Published Saudi data on diabetic foot outcomes are mostly retrospective and vary widely: amputation in 19% of ulcer patients at a Saudi Aramco programme, and in 60% of patients admitted with diabetic foot disorders across three Jeddah hospitals.
- In a Jeddah cohort of 556 people with diabetes, 3.6% developed an ulcer, gangrene or amputation within a year, so most patients are lower risk and risk stratification decides who needs close follow-up.
- A national diabetic foot program, reported in June 2026 by the Ministry of Health with professional societies and an industry partner, targets early identification of foot risk.
- Measure what a hospital controls: documented risk category, review within target, referral completion and recovery of missed visits.

On this page
What Saudi data say about outcomes
Saudi outcome data come from different settings, so they should not be compared directly. A prospective study at Saudi Aramco Medical Services Organization followed diabetic patients with foot ulcers referred to a wound care specialist and reported an amputation rate of 19%. Hypertension, peripheral vascular disease, absent pedal pulses and ischaemic heart disease were associated with amputation. A retrospective multicentre review of 229 files from three public hospitals in Jeddah looked at patients admitted with diabetic foot disorders: ulcer was the most common presentation (85.9%), and 60% of those admitted ended with a lower-limb amputation. Inpatients with advanced disease are a very different population from outpatients seen early.
The population view is different again. In a one-year follow-up of 556 people with diabetes in Jeddah, the cumulative incidence was 6.3% for peripheral arterial disease, 9.2% for peripheral neuropathy, 1.8% for foot ulcer, 1.5% for gangrene and 0.6% for amputation. Most patients do well, and a minority carry most of the risk. A follow-up program that treats everyone the same wastes clinic time; one that identifies the high-risk group and does not lose them is where the value is.
What the King Abdulaziz Medical City experience teaches
King Abdulaziz Medical City in Riyadh launched a diabetic foot care program in 2002. It combined education for staff and patients, practice protocols, referral guidelines for low- and high-risk foot problems, and early referral of high-risk patients to a specialist. A 2010 evaluation in Vascular Health and Risk Management reviewed 41 randomly chosen charts: amputation was 70% in the group treated before the program and 61.9% afterwards, a difference that was not statistically significant. The author reported greater awareness among patients and staff and called for a final evaluation.
The lesson is not that education does not work. It is that an early, small evaluation cannot prove outcomes, and that a program needs reliable follow-up machinery and measurement behind the education if it is to show results.
A national push on diabetic foot
In June 2026, Arab News reported that the Ministry of Health signed a memorandum with Boston Scientific, working with the Saudi Interventional Radiology Society and the Saudi Diabetic Foot Association, on a national program called Walk Safe. It aims to identify diabetic foot risk early to reduce amputations, starting with Ministry of Health hospitals and with plans to scale to more than 36 diabetes centres, seven of which include diabetic foot centres. Whatever the national program delivers, hospitals and private groups still need their own pathway for who is reviewed, how often and by whom.
What the program contains
Your diabetes, vascular and wound-care leads set the clinical content. A workable program has six parts:
- Risk classification. Every patient with diabetes seen in endocrine, primary care or inpatient settings has a documented foot risk category, using the scheme your clinical team has adopted.
- Education in Arabic. Foot-care teaching for patient and caregiver, repeated at follow-up and recorded.
- Scheduled reviews. Foot checks and wound-clinic visits at intervals set by risk category and ulcer status, not by who happens to book.
- Referral tracking. Vascular assessment, podiatry, orthopaedic and infection-team referrals tracked to completion. A referral that is made but not attended is a gap.
- Offloading and supplies. A record of footwear, dressings and offloading devices issued, so the next visit starts from what the patient actually has.
- Escalation and recall. Written rules for what triggers same-day review, and automatic recall when a visit is missed.
Where patients are lost
A patient with an ulcer may attend the wound clinic but never complete the vascular assessment, or be seen by endocrinology and surgery in different branches with no shared record. Reviews drift when they depend on the patient to call. The mechanics resemble a closed-loop referral process, and the multi-branch design questions are covered in our guide to a chronic disease management platform for multi-branch hospitals. Nurse and educator capacity matters too; see how patient educator management software organises that workload.
What a digital platform adds
A platform can hold the foot-risk registry, show each coordinator a worklist of overdue reviews and open referrals, send reminders in Arabic or English, collect a short structured questionnaire between visits, and give clinical leads a view of who is high risk and when they were last seen. Where wound photos are used, they are identifiable health images and need explicit consent and clear access rules. Our guide to remote patient monitoring for diabetes and hypertension covers the wider remote follow-up context. If any software function or device is used to inform clinical decisions, check whether SFDA medical-device requirements apply. A platform does not grade ulcers, decide on offloading or replace a clinician's examination.
An illustrative scenario
This is a hypothetical example, not a real patient. A 58-year-old man with type 2 diabetes and reduced foot sensation attends a hospital diabetes clinic in Riyadh. His foot is classified as high risk and a vascular assessment is requested. He misses the vascular appointment; the system shows it as overdue the next day and the coordinator calls his son, rebooks it and records the reason. At a later wound-clinic visit, the record shows the footwear he was given and the instructions repeated. The point is not the technology. It is that a missed visit is noticed in days instead of at the next crisis.
What to measure
Start with measures you can verify from your own data: share of patients with diabetes with a documented foot risk category, share of high-risk patients reviewed within the interval your team has set, share of referrals completed, time to recover a missed visit, and time from a flagged problem to clinician response. Amputation and healing outcomes should be reviewed by clinical governance and not attributed to a platform.
How CareSync supports this
CareSync Network is built for multi-branch hospitals that need one patient record, scheduling, secure messaging and configurable follow-up pathways across sites. For diabetic foot care, your team defines risk categories, review intervals and escalation rules; the platform runs the registry, reminders, referral tracking and overdue worklists in Arabic and English.
Frequently asked questions
What is a diabetic foot ulcer follow-up program?
A structured hospital pathway that classifies foot risk, schedules foot checks and wound reviews, tracks referrals to vascular, podiatry and surgical teams, and recalls patients who miss visits.
How often should high-risk patients be reviewed?
That is a clinical decision set by risk category and ulcer status, following the guideline your diabetes foot team has adopted. A platform should enforce the schedule your clinicians choose, not invent one.
What is the Walk Safe national program?
It is a national diabetic foot program reported in June 2026 involving the Ministry of Health, the Saudi Interventional Radiology Society, the Saudi Diabetic Foot Association and Boston Scientific, aimed at early identification of foot risk. Check official releases for current scope.
Can hospitals use wound photos in follow-up?
Only with explicit consent, defined access and secure storage, because the images are identifiable health data. Your clinical and data protection teams should approve the process.
Does follow-up need patient consent under PDPL?
Health data is sensitive personal data, so consent and a clear lawful basis for contact and sharing should be documented. Confirm requirements with your legal and data protection teams.
Sources
- Impact of a diabetic foot care education program on lower limb amputation rate, King Abdulaziz Medical City (2010)
- Diabetic foot ulcers in a Saudi Arabian hospital, risk factors and outcome (PubMed 19247012)
- Lower limb amputations among diabetics admitted with diabetic foot disorders in three major hospitals in Jeddah
- Incidence of diabetic foot disorders in patients with diabetes in Jeddah, Saudi Arabia (2015)
- Top Saudi institutions to tackle diabetes under new deal, Arab News, 25 June 2026